Clinical Trials Logo

Clinical Trial Summary

During two none subsequent natural menstrual cycles healthy female participants will be subjected every second day to blood sampling and 3D-ultrasound examinations. Together with four other key hormones the concentration of AMH (anti-Muellerian Hormone) will be measured in the serum.


Clinical Trial Description

During two none subsequent natural menstrual cycles healthy female participants will be subjected every second day to blood sampling and 3D-ultrasound examinations. Together with four other key hormones the concentration of AMH will be measured in the serum. Half of the serum samples will immediately be subjected to hormone analysis whereas the other half will be stored frozen at -80 °C. After conclusion of the study the frozen samples will be subjected to re-measurment again a reference laboratory. The aim is to study the stability of the AMH Elecsys Assay under both conditions. The participants will be health women aged between 18 and 40 years. They will be grouped into a younger and an older group. They will be observed during one menstrual cycle, then they will remain unobserved during a second menstrual cycle, and then again they will be observed during a third menstrual cycle. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06330259
Study type Observational
Source University of Basel
Contact
Status Completed
Phase
Start date July 1, 2017
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT02935738 - Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies N/A
Not yet recruiting NCT06193135 - Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA) N/A
Withdrawn NCT03191890 - Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device
Recruiting NCT05181748 - Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders Phase 2/Phase 3
Terminated NCT02652143 - Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy? N/A
Completed NCT03594201 - A Retrospective Study on the Effect of Male Progressive Sperm Count After Semen Pretreatment on ICSI Fertilization Outcome
Completed NCT05184777 - Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients N/A
Recruiting NCT05780489 - Evaluation of Salivary ELISA for Hormone Monitoring in Donors N/A